Top Markets
Coin of the day
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
株式のランク #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
株価
$0.49606484
最終同期: 2026-08-21
時価総額
$88.47M
変化(1日)
-1.58%
変化(1年)
-22.51%
TW
取引 Intech Biopharm Corporation (6461)

カテゴリー

Intech Biopharm Corporation(6461)の株式分割履歴
Intech Biopharm Corporation株(シンボル:6461)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 23, 2026に行われました。
Aug 23, 2026より前に購入された6461株は、現在06461株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH